ipamorelin cjc1295 buy CJC-1295 & Blend (10mg) Ipamorelin + CJC-1295 (No DAC)

Respir Med 108 , 647653

Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals

Hexarelin Peptide Hexarelin is a synthetic growth hormonereleasing peptide (GHRP-6 analogue) that has been examined in research settings for its ability to stimulate pulsatile GH release from the pituitary gland

Seriously, this short e-book will save you a lot of wasted money and poorly spent time (not to mention preventing you from potential self-inflicted missteps)

1997 May;136(5):445-60

Tesamorelin is not well-suited for patients whose primary goal is appetite suppression or scale weight loss